Arcadia Biosciences, Inc.

  • Market Cap: Micro Cap
  • Industry: Chemicals & Petrochemicals
  • ISIN: US0390143032
USD
3.64
-0.01 (-0.27%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Arcadia Biosciences, Inc. stock-summary
stock-summary
Arcadia Biosciences, Inc.
Chemicals & Petrochemicals
Arcadia Biosciences, Inc. is an agricultural biotechnology trait company. The Company develops a portfolio of yield and traits addressing multiple crops that supply the global food and feed markets. It has a pipeline of products in development incorporating its traits, including products that are in advanced stages of development or on the market. Its crop yield traits are utilized by its partners to develop higher yielding seeds for global crops, including wheat, rice, soybean, corn, and sugarcane, as well as for other crops, such as cotton, turf and trees. The Company's portfolio of agricultural productivity traits includes Nitrogen Use Efficiency (NUE), Water Use Efficiency (WUE), Drought Tolerance (DT), Salinity Tolerance (ST) and Herbicide Tolerance. It has presence in the United States, Africa, India, the United Arab Emirates, Belgium, France and Canada.
Company Coordinates stock-summary
Company Details
202 Cousteau Pl Ste 200 , DAVIS CA : 95618-7761
stock-summary
Tel: 1 530 7567077
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 2 Schemes (1.97%)

Foreign Institutions

Held by 4 Foreign Institutions (0.08%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Kevin Comcowich
Chairman of the Board
Mr. Matthew Plavan
Chief Executive Officer, Director
Jamie Bechtel
Director
Dr. Albert Bolles
Director
Peter Gajdos
Director
Ms. Lilian Shackleford Murray
Director
Mr. Gregory Waller
Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Jun 2025)
Net Profit:
-4 Million
stock-summary
Industry

Chemicals & Petrochemicals

stock-summary
Market cap

USD 4 Million (Micro Cap)

stock-summary
P/E

7.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.98

stock-summary
Return on Equity

-149.02%

stock-summary
Price to Book

0.99